De hyppigste bivirkninger ved Fabrazyme (som optræder hos flere end 1 ud af 10 patienter) skyldes infusionen snarere end medicinen.
The most common side effects with Fabrazyme (seen in more than 1 patient in 10) are caused by the infusion rather than the medicine.